GeNeuro SA (GNRO.PA)

EUR 0.06

(-4.72%)

Total Assets Summary of GeNeuro SA

  • GeNeuro SA's latest annual total assets in 2023 was 6.31 Million EUR , down -44.72% from previous year.
  • GeNeuro SA's latest quarterly total assets in 2023 FY was 6.31 Million EUR , down -44.72% from previous quarter.
  • GeNeuro SA reported annual total assets of 11.42 Million EUR in 2022, down -8.06% from previous year.
  • GeNeuro SA reported annual total assets of 12.42 Million EUR in 2021, up 19.02% from previous year.
  • GeNeuro SA reported quarterly total assets of 6.31 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • GeNeuro SA reported quarterly total assets of 12.2 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of GeNeuro SA (2023 - 2013)

Historical Annual Total Assets of GeNeuro SA (2023 - 2013)

Year Total Assets Total Assets Growth
2023 6.31 Million EUR -44.72%
2022 11.42 Million EUR -8.06%
2021 12.42 Million EUR 19.02%
2020 10.43 Million EUR 12.19%
2019 9.3 Million EUR 66094.85%
2018 14.05 Thousand EUR -53.73%
2017 30.36 Thousand EUR -19.62%
2016 37.78 Thousand EUR 81.96%
2015 20.76 Thousand EUR -99.77%
2014 9.05 Million EUR 115.83%
2013 4.19 Million EUR 0.0%

Peer Total Assets Comparison of GeNeuro SA

Name Total Assets Total Assets Difference
ABIONYX Pharma SA 14.71 Million EUR 57.084%
ABIVAX Société Anonyme 327.06 Million EUR 98.07%
Adocia SA 24.95 Million EUR 74.704%
Aelis Farma SA 26.28 Million EUR 75.979%
Biophytis S.A. 11.93 Million EUR 47.11%
Advicenne S.A. 12.4 Million EUR 49.118%
genOway Société anonyme 31.84 Million EUR 80.175%
IntegraGen SA 8 Million EUR 21.092%
Medesis Pharma S.A. 1.92 Million EUR -227.716%
Neovacs S.A. 47.53 Million EUR 86.719%
NFL Biosciences SA 3.97 Million EUR -58.99%
Plant Advanced Technologies SA 14.91 Million EUR 57.668%
Quantum Genomics Société Anonyme 3.74 Million EUR -68.489%
Sensorion SA 46.49 Million EUR 86.422%
Theranexus Société Anonyme 7.23 Million EUR 12.778%
TME Pharma N.V. 2.49 Million EUR -153.428%
Valbiotis SA 33.24 Million EUR 81.013%
TheraVet SA 7.53 Million EUR 16.21%
Valerio Therapeutics Société anonyme 35.27 Million EUR 82.103%
DBV Technologies S.A. 165.65 Million USD 96.189%
Genfit S.A. 173.87 Million EUR 96.369%
Innate Pharma S.A. 184.19 Million EUR 96.573%
Inventiva S.A. 69.13 Million EUR 90.869%
MaaT Pharma SA 42.93 Million EUR 85.295%
MedinCell S.A. 36.94 Million EUR 82.914%
Nanobiotix S.A. 93.89 Million EUR 93.277%
OSE Immunotherapeutics SA 81.9 Million EUR 92.292%
Poxel S.A. 4.82 Million EUR -30.892%
GenSight Biologics S.A. 9.08 Million EUR 30.528%
Transgene SA 45.21 Million EUR 86.039%
Valneva SE 469.39 Million EUR 98.655%